CNS Pharmaceuticals (CNSP) Earnings Analysis

CNS Pharmaceuticals (CNSP) next reports earnings on 2026-08-17, consensus EPS -0.24 USD. Last quarter (2026-05-14) it missed with EPS -7.3 USD vs -5.37 USD est (-35.9%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -0.20.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CNSP next report earnings?

Next earnings date2026-08-17
Consensus EPS estimate-0.24 USD
Revenue estimaten/a

CNSP earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-7.3 USD-5.37 USD-35.9%Miss
2026-03-31-5.09 USD-5.09 USD0%Beat
2025-11-14-5.76 USD-6.63 USD+13.1%Beat
2025-08-14-6.42 USD-9.6 USD+33.1%Beat
2024-11-14-150.06 USD-0.1 USD-149960%Miss
2024-08-14-4,033.61 USD-3,585.43111 USD-12.5%Miss

Beat rate: 3/6 (50%) over reported quarters with consensus data.

CNSP valuation and analyst view

Trailing P/E-0.20
Trailing EPS-24.3818 USD
Price / book55.47
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is CNS Pharmaceuticals (CNSP)'s next earnings date?

CNS Pharmaceuticals is next scheduled to report on 2026-08-17, with a consensus EPS estimate of -0.24 USD.

Did CNSP beat earnings last quarter?

In its 2026-05-14 report, CNSP posted EPS of -7.3 USD versus a -5.37 USD estimate — a miss of 35.9%.

What is CNSP's earnings track record?

Over the last 6 reported quarters with consensus data, CNSP beat estimates 3 times (50%).

What is CNSP's current P/E ratio and EPS?

CNSP trades at a trailing P/E of -0.20 on trailing EPS of -24.38179930550215 USD.

What do analysts rate CNSP?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell).